MRK vs NVDA: Which Is the Better Buy?
Side-by-side comparison of Merck & Co., Inc. and NVIDIA Corporation — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-09-26.
Merck & Co., Inc. · Healthcare
$147.17
-4.1% upside to fair value
Med Conviction
Grade C
VS
NVIDIA Corporation · Technology
$225.07
+45.0% upside to fair value
Med Conviction
Grade B
High Quality
QuantHub Verdict
NVDA has more upside to fair value
(+45.0%).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
MRK |
NVDA |
| Current Price |
$147.17 |
$225.07 |
| Fair Value Estimate |
$141.07 |
$326.35 |
| Upside to Fair Value |
-4.1%
|
+45.0%
|
| Market Cap |
$363.5B |
$5,451.4B |
| Forward P/E |
—
|
—
|
| EV / EBITDA |
29.6x
|
23.4x
|
| Price / Sales |
5.5x
|
18.0x
|
| Price / FCF |
22.6x
|
42.9x
|
| Revenue Growth YoY |
+5.1%
|
+105.9%
|
| Gross Margin |
75.4%
|
74.7%
|
| Operating Margin |
16.7%
|
65.2%
|
| Return on Equity |
6.6%
|
110.1%
|
| Dividend Yield |
2.31% |
0.23% |
| FCF Yield |
4.42%
|
2.33%
|
| Analyst Consensus |
Buy
|
Strong Buy
|
Investment Thesis
Merck & Co., Inc. is a global healthcare leader with two core divisions, Pharmaceuticals and Animal Health, spanning oncology, vaccines, acute hospital care, immunology, neuroscience, virology, cardiovascular and diabetes, and it employs roughly 74,000 people under CEO Robert Davis. The business quality is medium: TTM gross margin of 75.4% and TTM operating margin of 16.7% reflect a genuinely hig…
NVIDIA designs the accelerated computing platforms at the center of the AI buildout, spanning data center GPUs, Mellanox networking, AI enterprise software, gaming GeForce GPUs, professional visualization, and automotive platforms, with 42,000 employees and a $5.45 trillion market capitalization. Business quality is exceptional on the fundamentals: TTM gross margin of 74.7%, TTM operating margin …
Accumulation Zones
| Metric |
MRK |
NVDA |
| Zone Low |
$105.80 |
$244.76 |
| Zone High |
$119.91 |
$277.40 |
| In Buy Zone? |
No
|
Yes
|